Increased cardiovascular risk in patients with rheumatoid arthritis: an overview

被引:18
作者
Puttevils, Daisy [1 ]
De Vusser, Philip [2 ]
Geusens, Piet [3 ]
Dens, Jo [2 ]
机构
[1] Leuven Univ Hosp, Dept Cardiol, B-3000 Leuven, Belgium
[2] Ziekenhuis Oost Limburg, Dept Cardiol, Genk, Belgium
[3] Netherlands & Univ Hasselt, Maastricht Univ Med Ctrdep, Dept Rheumatol, Hasselt, Belgium
关键词
Cardiovascular risk; atherogenesis; rheumatoid arthritis; TNF antagonists; heart failure; NECROSIS-FACTOR-ALPHA; CONGESTIVE-HEART-FAILURE; IMPROVES ENDOTHELIAL FUNCTION; C-REACTIVE PROTEIN; CAUSE-SPECIFIC MORTALITY; LONG-TERM TREATMENT; ANTI-TNF THERAPY; INSULIN-RESISTANCE; INFLAMMATORY POLYARTHRITIS; MYOCARDIAL-INFARCTION;
D O I
10.1080/AC.69.2.3017291
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with established rheumatoid arthritis (RA) have a higher cardiovascular morbidity and mortality in comparison with the general population. It is considered to be an independent risk factor for cardiovascular disease. The purpose of this article is to describe the mechanisms responsible for accelerated atherogenesis in RA patients and to give an overview of the effects of different RA therapies (methotrexate, TNF antagonists and other biologicals).
引用
收藏
页码:111 / 118
页数:8
相关论文
共 91 条
[1]   How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH [J].
Anker, SD ;
Coats, AJS .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 86 (2-3) :123-130
[2]  
Aubry MC, 2007, J RHEUMATOL, V34, P937
[3]   Inflammatory and Autoimmune Mechanisms in the Induction of Atherosclerotic Damage in Systemic Rheumatic Diseases: Two Faces of the Same Coin [J].
Bartoloni, Elena ;
Shoenfeld, Yehuda ;
Gerli, Roberto .
ARTHRITIS CARE & RESEARCH, 2011, 63 (02) :178-183
[4]  
Bartoloni E, 2010, EXPERT REV CARDIOVAS, V8, P1309, DOI [10.1586/erc.10.123, 10.1586/ERC.10.123]
[5]   Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis [J].
Bernatsky, S ;
Hudson, M ;
Suissa, S .
RHEUMATOLOGY, 2005, 44 (05) :677-680
[6]   Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis [J].
Bilsborough, William ;
Keen, Helen ;
Taylor, Andrew ;
O'Driscoll, Gerard J. ;
Arnolda, Leonard ;
Green, Daniel J. .
RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) :1125-1131
[7]   Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins [J].
Bisoendial, Radjesh J. ;
Stroes, Erik S. G. ;
Kastelein, John J. P. ;
Tak, Paul Peter .
NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (03) :157-164
[8]   TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis [J].
Bosello, Silvia ;
Santoliquido, Angelo ;
Zoli, Angelo ;
Di Campli, Cristiana ;
Flore, Roberto ;
Tondi, Paolo ;
Ferraccioli, GianFranco .
CLINICAL RHEUMATOLOGY, 2008, 27 (07) :833-839
[9]   Treatment With Methotrexate Inhibits Atherogenesis in Cholesterol-Fed Rabbits [J].
Bulgarelli, Adriana ;
Martins Dias, Adriana Abalen ;
Caramelli, Bruno ;
Maranhao, Raul Cavalcante .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 59 (04) :308-314
[10]   All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists [J].
Carmona, Loreto ;
Descalzo, Miguel Angel ;
Perez-Pampin, Eva ;
Ruiz-Montesinos, Dolores ;
Erra, Alba ;
Cobo, Tatiana ;
Gomez-Reino, Juan J. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) :880-885